Experimental study demonstrates stable nanoliposome encapsulation of black soldier fly larvae oil, indicating improved potential for pharmaceutical delivery.
Black soldier fly larvae (BSFL) oil is a sustainable lipid with antimicrobial potential, yet its application is hindered by poor stability and undesirable odor. In this study, lyophilized nanoliposomes encapsulating BSFL oil were developed via thin-film hydration and freeze-drying, with process parameters optimized by single-factor and orthogonal experiments. The optimal conditions were pre-freezing at −80 °C for 12 h, drying for 24 h, 10% (w/v) β-lactose as lyoprotectant, and PBS (pH 7.0) for reconstitution. The resulting liposomes exhibited a mean size of 145.13 nm, PDI of 0.337, zeta potential of −46.76 mV, and encapsulation efficiency of 85.05%. TEM showed intact vesicular structures, while FTIR and XRD confirmed hydrogen-bonding stabilization and an amorphous glassy matrix. The in vitro release profile displayed no burst effect, indicating stable bilayer entrapment. Storage tests over 30 days demonstrated good stability at 4 °C and 25 °C, with encapsulation efficiency losses of only 3.99% and 6.2%, respectively, whereas 60 °C caused marked degradation. Collectively, this study establishes an optimized fre·eze-drying strategy for producing stable and redispersible BSFL oil nanoliposomes, with promising potential for further development in pharmaceutical and nutraceutical applications.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: